|
|
|
|
  |
| NOTICES |
|
| Notice No. |
|
20210623-10 |
|
Notice Date |
|
23 Jun 2021 |
|
| Category |
|
Corporate Actions |
|
Segment |
|
Equity |
|
| Subject |
|
Delisting of Companies |
|
|
|
|
|
| Content |
|
|
Trading Members of the Exchange are hereby informed that the under mentioned scrip code of the Company which has been suspended due to record date fixed for Corporate Action of Amalgamation shall be delisted with effect from June 24, 2021 (DR-059/2021-2022):
|
Sr. No
|
Scrip Code
|
ISIN No.
|
Name of the Company to be delisted
|
Date of Suspension
|
Reason
|
|
1
|
500676
|
INE264A01014
|
GlaxoSmithkline Consumer Healthcare Ltd.
|
16/04/2020
|
Merged with Hindustan Unilever Ltd
|
Mangesh Tayde
Asst. Gen. Manager –Listing Operations (CRD)
June 23, 2021 |
|